Correction: Randomized controlled trial comparing the safety and efficacy between the FUSION BIOLINE heparin-coated vascular graft and the standard expanded polytetrafluoro-ethylene graft for femoropopliteal bypass (Journal of Vascular Surgery (2015) 61 (703-12))

Comparison of Safety and Primary Patency Between the FUSION BIOLINE Heparin-Coated Vascular Graft and EXXCEL Soft ePTFE (FINEST) Trial Co-investigators

doi:10.1016/j.jvs.2015.03.013

Correction: Randomized controlled trial comparing the safety and efficacy between the FUSION BIOLINE heparin-coated vascular graft and the standard expanded polytetrafluoro-ethylene graft for femoropopliteal bypass (Journal of Vascular Surgery (2015) 61 (703-12))

Comparison of Safety and Primary Patency Between the FUSION BIOLINE Heparin-Coated Vascular Graft and EXXCEL Soft ePTFE (FINEST) Trial Co-investigators

Research output: Contribution to journal › Comment/debate

Original language	English (US)
Number of pages	1
Journal	Journal of Vascular Surgery
Volume	61
Issue number	5
DOIs	https://doi.org/10.1016/j.jvs.2015.03.013
State	Published - May 1 2015

ASJC Scopus subject areas

Surgery
Cardiology and Cardiovascular Medicine

Access to Document

10.1016/j.jvs.2015.03.013

Cite this

Comparison of Safety and Primary Patency Between the FUSION BIOLINE Heparin-Coated Vascular Graft and EXXCEL Soft ePTFE (FINEST) Trial Co-investigators (2015). Correction: Randomized controlled trial comparing the safety and efficacy between the FUSION BIOLINE heparin-coated vascular graft and the standard expanded polytetrafluoro-ethylene graft for femoropopliteal bypass (Journal of Vascular Surgery (2015) 61 (703-12)). Journal of Vascular Surgery, 61(5). https://doi.org/10.1016/j.jvs.2015.03.013

Correction : Randomized controlled trial comparing the safety and efficacy between the FUSION BIOLINE heparin-coated vascular graft and the standard expanded polytetrafluoro-ethylene graft for femoropopliteal bypass (Journal of Vascular Surgery (2015) 61 (703-12)). / Comparison of Safety and Primary Patency Between the FUSION BIOLINE Heparin-Coated Vascular Graft and EXXCEL Soft ePTFE (FINEST) Trial Co-investigators.

In: Journal of Vascular Surgery, Vol. 61, No. 5, 01.05.2015.

Research output: Contribution to journal › Comment/debate

Comparison of Safety and Primary Patency Between the FUSION BIOLINE Heparin-Coated Vascular Graft and EXXCEL Soft ePTFE (FINEST) Trial Co-investigators 2015, 'Correction: Randomized controlled trial comparing the safety and efficacy between the FUSION BIOLINE heparin-coated vascular graft and the standard expanded polytetrafluoro-ethylene graft for femoropopliteal bypass (Journal of Vascular Surgery (2015) 61 (703-12))', Journal of Vascular Surgery, vol. 61, no. 5. https://doi.org/10.1016/j.jvs.2015.03.013

Comparison of Safety and Primary Patency Between the FUSION BIOLINE Heparin-Coated Vascular Graft and EXXCEL Soft ePTFE (FINEST) Trial Co-investigators. Correction: Randomized controlled trial comparing the safety and efficacy between the FUSION BIOLINE heparin-coated vascular graft and the standard expanded polytetrafluoro-ethylene graft for femoropopliteal bypass (Journal of Vascular Surgery (2015) 61 (703-12)). Journal of Vascular Surgery. 2015 May 1;61(5). https://doi.org/10.1016/j.jvs.2015.03.013

Comparison of Safety and Primary Patency Between the FUSION BIOLINE Heparin-Coated Vascular Graft and EXXCEL Soft ePTFE (FINEST) Trial Co-investigators. / Correction : Randomized controlled trial comparing the safety and efficacy between the FUSION BIOLINE heparin-coated vascular graft and the standard expanded polytetrafluoro-ethylene graft for femoropopliteal bypass (Journal of Vascular Surgery (2015) 61 (703-12)). In: Journal of Vascular Surgery. 2015 ; Vol. 61, No. 5.

@article{f092a3552106433785f5bec1d42b6137,

title = "Correction: Randomized controlled trial comparing the safety and efficacy between the FUSION BIOLINE heparin-coated vascular graft and the standard expanded polytetrafluoro-ethylene graft for femoropopliteal bypass (Journal of Vascular Surgery (2015) 61 (703-12))",

author = "{Comparison of Safety and Primary Patency Between the FUSION BIOLINE Heparin-Coated Vascular Graft and EXXCEL Soft ePTFE (FINEST) Trial Co-investigators} and Lumsden, {A. B.} and Morrissey, {N. J.}",

year = "2015",

month = may,

day = "1",

doi = "10.1016/j.jvs.2015.03.013",

language = "English (US)",

volume = "61",

journal = "Journal of Vascular Surgery",

issn = "0741-5214",

publisher = "Mosby Inc.",

number = "5",

}

TY - JOUR

T1 - Correction

T2 - Randomized controlled trial comparing the safety and efficacy between the FUSION BIOLINE heparin-coated vascular graft and the standard expanded polytetrafluoro-ethylene graft for femoropopliteal bypass (Journal of Vascular Surgery (2015) 61 (703-12))

AU - Comparison of Safety and Primary Patency Between the FUSION BIOLINE Heparin-Coated Vascular Graft and EXXCEL Soft ePTFE (FINEST) Trial Co-investigators

AU - Lumsden, A. B.

AU - Morrissey, N. J.

PY - 2015/5/1

Y1 - 2015/5/1

UR - http://www.scopus.com/inward/record.url?scp=84929999933&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929999933&partnerID=8YFLogxK

U2 - 10.1016/j.jvs.2015.03.013

DO - 10.1016/j.jvs.2015.03.013

M3 - Comment/debate

AN - SCOPUS:84929999933

VL - 61

JO - Journal of Vascular Surgery

JF - Journal of Vascular Surgery

SN - 0741-5214

IS - 5

ER -